Registry following children in China with rheumatic and immune diseases
Records long-term health of children under 18 with autoimmune conditions.
Plain-language title generated from the registry record
Registry title: Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry
Key facts
- Where
- Beijing, Changsha, Chongqing, Hangzhou, Nanjing, and Shenzhen, ChinaSee the 9 sites
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children and teenagers up to 18 years old who have a rheumatic or immune disease and were diagnosed and treated in China.
- Age
- Up to 18 years old
- Sex
- All sexes can join
- Disease stage
- Rheumatic and immunologic diseases, including diffuse connective tissue diseases, arthritis, vasculitis and inborn errors of immunity
- Earlier treatment
- Must have been diagnosed and treated in China
Main reasons for not taking part
- The patient or family does not agree to take part in the study
Read by machine on 9 November 2026.
Where in China
- Beijing Children's Hospital, Capital Medical UniversityBeijing, ChinaTaking people
- Peking Union Medical College HospitalBeijing, ChinaTaking people
- Third Hospital of Peking UniversityBeijing, ChinaTaking people
- The Second Xiangya Hospital of Central South UniversityChangsha, ChinaTaking people
- Chidren's Hospital of Chongqing Medical UniversityChongqing, ChinaTaking people
- Children's Hospital of Zhejiang University School of MedicineHangzhou, ChinaTaking people
- Children's Hospital of Nanjing Medical UniversityNanjing, ChinaTaking people
- Shenzhen Children's HospitalShenzhen, ChinaTaking people
- The University of Hong Kong Shenzhen Institute of Research and Innovation (HKU-SIRI)Shenzhen, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Peking Union Medical College Hospital
- Trial code
- NCT06417502
- Record updated
- 16 May 2024
- Original description
An observational, multi-center, longitudinal registry study for Chinese pediatric patients with rheumatic and immunologic diseases.Read full original descriptionShow less
Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry
An observational, multi-center, longitudinal registry study for Chinese pediatric patients with rheumatic and immunologic diseases.
Inclusion: Age <= 18 years old; Diagnosed with rheumatic and immunologic diseases (including diffuse connective tissue diseases, arthritis, vasculitis, inborn errors of immunity); Diagnosed and Treated in China.
Exclusion: Disagreement of involving in this study by the patient or his/her family.